Governance bioMérieux

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 16:55:00 18/07/2025 BST			5-day change	1st Jan Change
118.40 ^EUR	+0.08%		-0.75%	+14.40%

07-15	AlphaValue/Baader Europe Ups BioMérieux Price Target	MT
07-14	BIOMÉRIEUX : AlphaValue raises target price

Executive Committee: bioMérieux

Manager

Positions heldSince

Pierre Boulud

53 year

Chief Executive Officer

30/06/2023

Audrey Dauvet

General Counsel

31/12/2022

Charles Cooper

Chief Tech/Sci/R&D Officer

01/01/2024

Jennifer Zinn

Chief Tech/Sci/R&D Officer

31/07/2023

Guillaume Bouhours

49 year

Chief Tech/Sci/R&D Officer	28/02/2018
Director of Finance/CFO	28/02/2018

Valérie Leyldé

Human Resources Officer	-
Public Communications Contact	-

Composition of the Board of Directors: bioMérieux

Director

CommitteesSince

Alexandre Mérieux

51 year

Compensation Committee Chair

25/04/2018

Jean-Luc Bélingard

75 year

Compensation Committee	17/12/2017
HR Committee	17/12/2017
Compensation Committee Chair	24/08/2020
Nominating Committee Chair	24/08/2020

Viviane Monges

60 year

Audit Committee Chair	28/06/2021
Governance Committee	10/06/2021
Nominating Committee	10/06/2021

Philippe Archinard

64 year

Audit Committee	22/06/2023
Compensation Committee	22/06/2023
Nominating Committee	22/06/2023

Fanny Letier

46 year

Audit Committee
Compensation Committee Chair	29/06/2017
HR Committee Chair	29/06/2017

Benoît Ribadeau-Dumas

53 year

Compensation Committee	12/04/2023
Governance Committee	06/05/2024
Nominating Committee	06/05/2024

Marie-Hélène Habert-Dassault

60 year

Compensation Committee	14/11/2012
HR Committee	14/11/2012

Sylvain Orenga

Compensation Committee	23/05/2022
HR Committee	23/05/2022

Harold Y. H. Boël

60 year

Audit Committee Chair

14/11/2012

Marie-Paule Kieny

69 year

Director/Board Member	27/08/2017
Independent Dir/Board Member	27/08/2017

Latest Appointments: bioMérieux

Aurobac Therapeutics, founded by Boehringer Ingelheim, bioMerieux and Evotec, Names Scientific Advisory Board	30/06/24	CI
BioMérieux S.A Recommends Dividend, Payable on May 17, 2018, Announces Executive Changes	28/02/18	CI
BioMérieux Announces Management Changes	15/12/17	CI
BioMérieux S.A. Acknowledges the Appointment of Michel Baguenault as Secretary General	02/09/16	CI
BioMérieux Announces Board Changes	28/05/14	CI
Alexandre Mérieux Assumes Role of bioMérieux's Chief Executive Officer and Head of Its Management Committee	15/04/14	CI
BioMérieux SA Appoints Claire Giraut as Corporate Vice President and CFO	05/02/14	CI

More news

Former Officers and Directors: bioMérieux

Insider

Positions held

SinceUntil

François Lacoste

Chief Tech/Sci/R&D Officer

29/02/2024

Mark Miller

Chief Tech/Sci/R&D Officer

01/11/2012

01/01/2024

Agnès Lemarchand

Director/Board Member	27/05/2014	22/03/2023
Independent Dir/Board Member	27/05/2014	22/03/2023

Esther Wick

Compliance Officer	31/12/2016	31/08/2022
General Counsel	31/12/2016	31/08/2022

Frédéric Besème

Director/Board Member

16/05/2018

23/05/2022

Sandrine Flory

Corporate Officer/Principal

31/12/2013

31/12/2019

Claire Giraut

Director of Finance/CFO	31/12/2013	27/02/2018
Corporate Officer/Principal	31/08/2013	31/12/2013

Michel Baguenault de Puchesse

Human Resources Officer	31/12/2010	31/12/2015
Public Communications Contact	31/12/2010	31/12/2015
Corporate Secretary	31/12/2010	31/12/2015

Marcello Damiani

Chief Tech/Sci/R&D Officer

31/12/2008

31/12/2014

Philippe Gillet

Director/Board Member	27/05/2014	-
Independent Dir/Board Member	27/05/2014	-

Michel Angé

Director/Board Member	-	27/05/2014
Independent Dir/Board Member	-	27/05/2014

Georges Hibon

Director/Board Member

21/04/2010

31/12/2013

Manuel Méndez Muñiz

Corporate Officer/Principal

18/05/2010

31/12/2013

Henri Thomasson

Director of Finance/CFO	21/04/2010	-
General Counsel	21/04/2010	31/12/2013

Christian Brechot

Director/Board Member

31/12/2011

Eileen C. Pruette

Corporate Officer/Principal

31/12/2011

Gentiane Gorlier

General Counsel	31/12/2003	30/10/2011
Corporate Officer/Principal	31/12/2003	30/10/2011

Stéphane Bancel

Chief Executive Officer

31/12/2006

30/06/2011

Eric Bouvier

Corporate Officer/Principal

21/04/2010

31/03/2011

James P. Whelan

Corporate Officer/Principal

04/01/2011

Philippe Cleuziat

Director/Board Member

05/11/2009

20/04/2010

Mojgan Lefebvre

Chief Tech/Sci/R&D Officer

31/12/2006

31/12/2009

Jean-Fabien Monin

Director of Finance/CFO

30/11/2006

28/02/2009

Richard Ding

Corporate Officer/Principal

31/12/2005

31/12/2007

Jean François Carmier

Corporate Officer/Principal

31/12/2006

Michele Palladino

Director/Board Member	05/07/2004	-
Independent Dir/Board Member	05/07/2004	-
Chief Executive Officer	-	31/12/1992

Benoît Habert

Director/Board Member	21/04/2010	-
Independent Dir/Board Member	15/04/2004	-

Carinne Knoche-Brouillon

Sales & Marketing

31/12/1990

31/12/1994

Christine Ginocchio

Chief Tech/Sci/R&D Officer

Henri Thomasson

Director/Board Member

Thibaut du Fayet

Sales & Marketing

Éric Trappier

Director/Board Member

Pablo Jordan

Corporate Officer/Principal

Stefan Willemsen

General Counsel	-	-
Corporate Officer/Principal	-	-

Thierry Delair

Corporate Officer/Principal

Stephen Harbin

Chief Tech/Sci/R&D Officer	03/10/2012	-
General Counsel	03/10/2012	-
Corporate Officer/Principal	21/04/2010	03/10/2012

Dominique Takizawa

Public Communications Contact

16/09/2009

Herve Laurent

Public Communications Contact

16/09/2009

Isabelle Tongio

Investor Relations Contact

Alain Pluquet

Chief Tech/Sci/R&D Officer	-	-
Corporate Officer/Principal	-	-

Thierry Bernard

Corporate Officer/Principal

21/04/2010

Jean-Marc Durano

Corporate Officer/Principal

21/04/2010

Peter Kaspar

Corporate Officer/Principal

21/04/2010

Nicolas Cartier

Corporate Officer/Principal

Bruce Draper

Corporate Officer/Principal

Erik Jan Zimmer

Corporate Officer/Principal

Jacques de Jong

Chief Tech/Sci/R&D Officer

Richard F. Labaudinière

Corporate Officer/Principal

Koren Wolman-Tardy

Public Communications Contact

Bernard Gilly

Chief Tech/Sci/R&D Officer

James Kropp

Director of Finance/CFO

Alain Mérieux

Director/Board Member	31/12/1962	30/04/2017
Chairman	17/12/2017	-
Founder	31/12/1962	-
Independent Dir/Board Member	31/12/1962	30/04/2017

Age distribution of managers

Parity Men Women

Male	12
Female	7

Of which Executive Committee

Male	3
Female	3

Of which Directors

Male	6
Female	4

Revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

Revenue revisions (1 month)

EPS revisions (1 year)

EPS revisions (4 months)

ESG MSCI

ESG

Environment

Social

Governance

Controversy

Ethical controversies

Human rights controversies

Tax subsidies controversies

Sharia compliant

bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows: - medical applications (84.8%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors; - industrial applications (15.2%). The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East/Africa (31.9%), North America (45%), Asia/Pacific (16,5%) and Latin America (6.6%).

Employees

14,451

Sector

Medical Equipment, Supplies & Distribution

Calendar

09-03 - Q2 2025 Earnings Release

More about the company